Shields Health Solutions

What Shields Health Solutions does

Shields Health Solutions is a U.S. specialty pharmacy accelerator that partners with hospitals, health systems, and academic medical centers to build and operate integrated specialty pharmacy programs. The company serves nearly 80 health system partners across approximately 1,000 hospitals and clinics in nearly all 50 states, representing more than 7 million patients across 30+ integrated disease states. Shields delivers a combined offering of on-site clinical pharmacy staff, centralized support services, payer and limited distribution drug (LDD) access, and the proprietary TelemetryRx® data analytics platform, which integrates with electronic medical records to identify eligible patients, automate workflows, and produce standardized real-world data reporting. The company is headquartered in Stoughton, Massachusetts, and operates as a private standalone company owned by Sycamore Partners following its August 2025 carve-out from Walgreens Boots Alliance, with a significant minority preferred stock position held by Evernorth Health Services (Cigna Group) via a $3.5 billion investment announced in September 2025.

Shields generates revenue through managed services arrangements with health system partners, including dispensing specialty medications, pharmacy management fees, and performance-based contracts. Two primary customer segments are served: (1) health systems and providers seeking to overcome limited payer network access, operational complexity, and reimbursement pressures in specialty pharmacy, and (2) pharmaceutical manufacturers seeking pipeline management, network strategy, and real-world data access through the TelemetryRx platform. The company holds URAC Specialty Pharmacy accreditation and reports strong operational outcomes, including 92% medication adherence (vs. 80% industry standard), under-two-day time to therapy, and a 13% reduction in total cost of care. As of late 2025, Shields employs more than 3,000 people, generates approximately $700 million in trailing twelve-month revenue, and reported adjusted operating income exceeding $200 million for FY2024.

Name

Shields Health Solutions

Legal name

Shields Health Solutions

Website

https://shieldshealthsolutions.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Shields Health Solutions is a U.S. specialty pharmacy accelerator that partners with nearly 80 health systems to operate integrated specialty pharmacy programs, leveraging its proprietary TelemetryRx® data platform, payer and limited distribution drug access, and clinical care teams to improve adherence and reduce total cost of care for patients with chronic and complex conditions.

Ownership category

akta.pro rank

Product category

Specialty Pharmacy Services

NAICS

Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

Keywords

• Specialty pharmacy services
• Health system partnerships
• Pharmacy data analytics
• Specialty medication access
• Patient care coordination

Headquarters

HQ city

Stoughton

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Specialty Pharmacy Services: Shields generates revenue through managing specialty pharmacy operations for health system partners. The company earns revenue from dispensing specialty medications, pharmacy management fees, and performance-based arrangements with health systems.
2. Health System Partnership Fees: Revenue generated through strategic partnerships with health systems, providing access to payer networks, limited distribution drugs, and comprehensive specialty pharmacy care coordination.
3. Drug Manufacturer Services: Services for drug manufacturers including pipeline management, network strategy, and TelemetryRx data aggregation. Helps manufacturers access health system specialty pharmacy networks and gather real-world data.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

Shields Health Solutions is a specialty pharmacy accelerator that partners with hospitals, health systems, and academic medical centers to build, manage, and operate integrated in-house specialty pharmacy programs. The company provides on-site and centralized clinical pharmacists, pharmacy liaisons, payer and limited distribution drug access, and its proprietary TelemetryRx data analytics platform to coordinate care for patients with complex and chronic conditions. It also offers drug manufacturers pipeline management, network strategy, and real-world data aggregation services.

Product overview

Shields Health Solutions operates as a specialty pharmacy accelerator providing an integrated platform of solutions, services, and technology. The core offering consists of the proprietary TelemetryRx® Data Analytics platform combined with a comprehensive care model that provides clinical pharmacy services, payer and drug access, and data-driven workflows. The company serves nearly 80 health system partners across over 1,000 hospitals and clinics, offering solutions for providers (increasing access to payers and limited distribution drugs) and drug manufacturers (pipeline management, network strategy, rare disease support). Additional programs include the Diabetes Care Coach telehealth program and partnerships for AI-powered prior authorization automation.

Differentiator

Problem solved

Functional benefit

Brands

• TelemetryRx®: Proprietary software platform that streamlines patient care and reporting through enhanced patient enrollment, data-driven workflows and advanced analytics for specialty care teams. The platform is designed to increase patient retention by 40-60 percent and helps identify high-risk patients who would benefit from enhanced clinical management.

Products and services

• Specialty Pharmacy Care Model

Quantifiable outcome

• 92% patient medication adherence rate vs. 80% industry standard
• +6 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability6 records

Feature3 records

Partnerships

Five partnerships are on record, tiered core.

• Columbus Regional HealthcoreStrategic or Co-development Partner · 22 April 2026Partnership to expand specialty pharmacy services in Indiana, supporting over 8,000 patients with complex conditions. Collaboration includes personalized care, improved medication adherence, and reduced out-of-pocket costs, with plans to expand into more disease areas. Initiative aims to enhance care coordination and access to critical therapies.
• Foundation HealthcoreTechnology or Integration · 13 January 2026Strategic partnership to integrate Foundation Health's AI-powered pharmacy technology into Shields' specialty pharmacy services nationwide. Initial focus on prior authorizations before expanding to medication adherence, patient experience, financial assistance, and care coordination. Shields also made a significant investment in Foundation Health to advance AI-enabled technology across specialty pharmacy workflows.
• Lakeland Regional HealthcoreStrategic or Co-development Partner · 12 November 2025Partnership to improve patient access to specialty medications for chronic and complex health conditions including cancer, multiple sclerosis, and autoimmune diseases. Collaboration integrates Shields' specialty pharmacy care model into Lakeland Regional Health's provider network, initially focusing on oncology and rheumatology before expanding to additional specialties.
• Duke HealthcoreStrategic or Co-development Partner · 13 May 2025Partnership with major academic medical center to expand specialty pharmacy services in North Carolina. Designed to better support patients through lower costs, broader treatment options, and enhanced medication management. Duke Specialty Pharmacy patients receive personalized, patient-centered care including increased medication adherence, regular follow-ups, side effects management, access to financial assistance, and medication delivery.
• Sutter HealthcoreStrategic or Co-development Partner · 24 October 2024Expanded partnership to enhance patient access to specialty pharmacy services, supporting nearly 3,000 providers. Collaboration initially focused on treatments for cancer, rheumatology, and dermatology, with plans to expand to additional specialties.

Scale indicators14 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Trellis Rx: Health-system specialty pharmacy accelerator offering similar on-site and centralized services to hospitals. Acquired by Walgreens Boots Alliance in 2023 and is the closest direct competitor to Shields' accelerator model.
• Avita Pharmacy: Specialty pharmacy provider partnering with health systems and community health centers to dispense specialty medications and coordinate patient care. Comparable in serving underserved populations and complex conditions.
• ProxsysRx: Health-system specialty pharmacy management company offering technology and operational support to hospital-owned specialty pharmacies. Directly competes for the same health-system specialty pharmacy contracts.
• Altruix: Specialty pharmacy services provider focused on health systems, behavioral health, and HIV communities. Comparable model of partnering with provider organizations to dispense and manage specialty medications.
• Amber Specialty Pharmacy: Specialty pharmacy serving patients with complex conditions including oncology, rare diseases, and transplant. Operates a health-system partnership model with similar payer and manufacturer services.

Broad incumbents

• Optum Specialty Pharmacy: Specialty pharmacy arm of Optum Rx (UnitedHealth Group), serving broad populations through vertically integrated payer-PBM-pharmacy capabilities. Competes with Shields for LDD access and payer relationships at national scale.
• CVS Specialty (CVS Health): Specialty pharmacy division of CVS Health combining retail, PBM (Caremark), and specialty dispensing. A broad incumbent overlapping with Shields on payer contracts, LDD access, and drug manufacturer services.
• Accredo (Express Scripts / Cigna): Specialty pharmacy owned by Cigna's Express Scripts, focused on complex and chronic conditions. Competes with Shields while also relevant given Evernorth's $3.5B investment in Shields.
• Walgreens Specialty Pharmacy: Specialty pharmacy business of Walgreens, previously Shields' corporate parent via WBA. Represents a large incumbent competitor in retail and central-fill specialty pharmacy channels.
• McKesson (Specialty Pharmacy Solutions): Specialty distribution and pharmacy services through McKesson, including the US Oncology Network. Competes with Shields on drug distribution, LDD access, and manufacturer services at enterprise scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/shields_rx
• YouTubeyoutube.com/channel/UCqE5LUW1shh3qUhR6_bIxyg
• Facebookfacebook.com/shieldshealthsolutions
• LinkedInlinkedin.com/company/shields-health-solutions

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Shields Health Solutions